Direct links to posters below. For the second poster, if you go here, and then here, there is a little play slide button at the botton for the audio presentation.

The BET Protein Inhibitor Apabetalone Reduces Congestive Heart Failure Incidence in Patients with Acute Coronary Syndrome and Diabetes: Results from the BETonMACE Trial

https://www.resverlogix.com/upload/media_element/211/f0349a682cf0/2020-03-16---chf-poster-final.pdf

Epigenetic Reader Inhibitor Apabetalone (RVX-208) Counters Proinflammatory Hyperactivation of CD14+ Monocytes from Patients with Type 2 Diabetes and Cardiovascular Disease

https://www.resverlogix.com/upload/media_element/212/e85e05b65cdc/acc2020-mela-moderated-poster-final.pdf

BDAZ